Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Viatris Inc
(NQ:
VTRS
)
10.96
-0.11 (-0.99%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viatris Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
India's Biocon Mulls Merger Of Biosimilar Business With Mylan: Moneycontrol
December 09, 2021
India-based Biocon Ltd is reportedly in talks with generic drugmaker Mylan for a merger of their biosimilar businesses, financial news website ...
Via
Benzinga
The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case
December 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Adcom Backing For Oral COVID-19 Antiviral Medication Molnupiravir...
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
7 Drug Stocks to Buy Now While They’re Still on Sale
November 30, 2021
Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead.
Via
InvestorPlace
Topics
Supply Chain
Exposures
COVID-19
Supply Chain
Unusual Options Activity Insight: Viatris
August 09, 2021
On Monday, shares of Viatris (NASDAQ:VTRS) saw unusual opt...
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
Biogen Loses Bid To Revive Tecfidera Drug Patent: Bloomberg
November 30, 2021
Biogen Inc (NASDAQ: BIIB) lost its appeals court bid to revive a key patent on the blockbuster multiple sclerosis drug Tecfidera, reports Bloomberg. In a related ruling...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Is It Too Late to Buy Viatris Stock?
November 30, 2021
It's not too late if you're looking for dividend income.
Via
The Motley Fool
7 Stocks 'On Sale' This Holiday Season
November 26, 2021
This time of year, it may feel like you’ve missed out on big rallies in the best stocks. But, there may still be a chance to buy some high-quality stocks for 2022 at a discount to what you would have...
Via
Talk Markets
7 Stocks 'On Sale' This Holiday Season
November 26, 2021
The SPDR S&P 500 ETF Trust (NYSE: SPY) has generated a total return of 26.4% year-to-date, but much of those overall gains have been driven by a handful of megacap stocks. In...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
3 Pharma Stocks That Are Too Cheap to Ignore
November 25, 2021
Many stocks are ridiculously expensive right now -- but not these three.
Via
The Motley Fool
Novartis May Have Buyer(s) For Its Sandoz Unit - Report
November 23, 2021
According to a German newspaper, Swedish-based investment group EQT and the Struengmann family of Germany are considering a joint move to purchase the Novartis AG...
Via
Benzinga
New Alternatives for Branded Biologics
November 22, 2021
We’ve all heard about generic drugs. They are time-tested and battle-proven medicines that are more affordable than their patented predecessors. Branded drugs consistently...
Via
Benzinga
7 Stocks to Buy for Their Resistance to the 6.2% Monthly Inflation
November 22, 2021
These companies either have no exposure to inflation or have strong branding and customer loyalty, enabling them to pass higher costs.
Via
InvestorPlace
3 Things About Viatris That Smart Investors Know
November 21, 2021
Don't expect it to follow the trajectory of a hot growth stock.
Via
The Motley Fool
Johnson & Johnson Pops As It Announces The Biggest Split In Health Care
November 12, 2021
Johnson & Johnson will split its consumer health unit into a publicly traded company.
Via
Investor's Business Daily
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
Could Viatris Stock Help You Retire a Millionaire?
October 23, 2021
It depends on how much help you're looking for.
Via
The Motley Fool
Topics
Retirement
Exposures
Pension
Earnings Scheduled For November 8, 2021
November 08, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •...
Via
Benzinga
3 No-Brainer Biotech Stocks to Buy Right Now
October 16, 2021
Regeneron Pharmaceuticals, Vertex Pharmaceuticals, and Viatris should have plenty of room to run.
Via
The Motley Fool
2 Ultra-Cheap Stocks Trading Below Their Book Values
October 07, 2021
And these stocks also pay relatively high dividends.
Via
The Motley Fool
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Viatris Inc. and Encourages Investors who Formerly Held Shares of Mylan Inc. (MYL) to Contact the Firm
September 29, 2021
From
The Schall Law Firm
Via
Business Wire
Why Are Theravance Bio Shares Plummeting Premarket Today?
September 15, 2021
Theravance Biopharma Inc (NASDAQ: TBPH) will reduce its headcount by approximately 75% (estimated 270 positions), with most of the lay off to complete in November...
Via
Benzinga
Why Wall Street Thinks This Dirt Cheap Value Stock Could Soar
September 13, 2021
It's kind of a boring stock. But analysts think that it could deliver not-so-boring growth.
Via
The Motley Fool
Got $5,000? These 2 Dividend Stocks Are Dirt Cheap Buys
September 02, 2021
And their yields are both over 3%.
Via
The Motley Fool
3 Things About Pfizer That Smart Investors Know
August 31, 2021
They're all about the future.
Via
The Motley Fool
Theravance Stock Crashes; Can Longer Testing Salvage Its J&J-Partnered Drug?
August 24, 2021
Theravance said late Monday its ulcerative colitis treatment failed in midstage testing, and the biotech stock plummeted early Tuesday.
Via
Investor's Business Daily
3 Top Biotech Stocks to Buy in August
August 17, 2021
Each of these companies makes for a great vehicle to play an aging demographic.
Via
The Motley Fool
Analysts Love This Newly Formed Healthcare Company; Should You?
August 16, 2021
Viatris' steady operating results and cheap valuation are two key reasons for its high one-year price target.
Via
The Motley Fool
Viatris Inc (VTRS) Q2 2021 Earnings Call Transcript
August 09, 2021
VTRS earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Earnings Scheduled For August 9, 2021
August 09, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •...
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.